Mindo pharma specializing in the R&D , production and trading of pharmaceutical intermediates and raw materials.

The company's R&D center is located in China Medical City, Taizhou City, Jiangsu Province, with an area of about 1000 square meters. The company is mainly engaged in the development and production of pyrazole, imidazole, pyridazine, pyrazine derivatives, indole, indole-indole, indole-indole, indole-indole-indole derivatives, and at present, there are more than 20,000 related compounds in the stockpile.

So far, our company has established good cooperation with many domestic CRO enterprises. Our production base is located in Laixian County, Anhui Province, the conventional reaction temperature is -10~150, and we are good at catalytic hydrogenation, substitution reaction, condensation reaction, etc. We have also reached agreements with GMP and FDA companies. Our company has also reached long-term cooperation agreements with GMP and FDA enterprises, for customers with high qualification requirements, we can cooperate with GMP and FDA enterprises in the form of project transfer or subcontracting, in order to meet the documentation and audit requirements of domestic and foreign customers.